跳至主要内容
临床试验/TCTR20220308003
TCTR20220308003已完成4 期

Efficiency of azelastine hydrochloride and fluticasone propionate nasal spray to improve PAP adherence in patients with obstructive sleep apnea :A Double-blinded Randomized Controlled Trial

Thammasat University Hospital0 个研究点目标入组 116 人开始时间: 2022年3月8日最近更新:
适应症

试验速览

阶段
4 期
状态
已完成
入组人数
116

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 Years 至 75 Years(—)
性别
All

入选标准

  • 1. First time diagnosis of Obstrutive sleep apnea in Thammasat university hospital
  • 2. Age beween 18 to 75 year
  • 3. Willingness to volunteer to participate in the trial and sign yhe informed consent form

排除标准

  • 1. use of any intranasal corticosteroids during the last 3 months
  • 2. any serious impair cognitive function or dementia or psychological disorder likely to preclude completion of the trial
  • 3. any disease that have indication to use Intranasal corticosteroid
  • 4. any other sleep disorder eg. Narcolepsy, Insomnia, Parasomnia, Central sleep apnea

研究者

相似试验

Efficiency of azelastine hydrochloride and... | 临床试验